News

Elite Clinical Network (ECN) has appointed Christopher (“Chris”) Brennan as its Chief Executive Officer. With 25 years of leadership experience at pharmaceutical service companies and drug development companies, Chris brings both breadth and depth of industry knowledge to ECN. This experience will allow him to lead the company to realize its strategy of aggressive growth in ECN’s capabilities set and clinical site network.

Giammona will help to lead ECN’s strategy and growth initiatives as the company continues to expand both its geographic footprint and full array of service offerings to the the clinical trials industry – from expanded early development/Phase 1 services through Phase 4 trials.

The partnership will focus on embedding clinical research opportunities directly into community-based care, with special attention to underserved areas. It also introduces new digital engagement strategies to streamline patient recruitment and retention while supporting hybrid and decentralized trial models. These efforts will ultimately support the delivery of high-quality data across a wide range of therapeutic areas for sponsors and CROs.

Elite Clinical Network (ECN) is pleased to announce Chip Gillooly Appointed Operating Partner of Elite Clinical Network. As Operating Partner to ECN and Surge, Chip will work with the board and leadership team to manage the rapid growth the company is experiencing and secure increased enterprise value for the firm.